Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


1 Arch Med Res
1 Cancer Lett
1 Cancer Treat Rev
2 Cell Physiol Biochem
1 Cell Signal
1 Contemp Clin Trials Commun
1 Curr Urol
1 EBioMedicine
1 Epigenomics
1 Eur J Surg Oncol
1 Int J Oncol
1 J Cell Biochem
1 Medicine (Baltimore)
1 Mol Med Rep
1 Nanomaterials (Basel)
1 Onco Targets Ther
1 Transl Res
1 Urol Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Arch Med Res

  1. IFTIMIE S, Garcia-Heredia A, Pujol-Bosch F, Pont-Salvado A, et al
    Serum Paraoxonase-1 Concentration as a Potential Predictor of Urinary Bladder Cancer Recurrence. A Five Year Follow-Up Study.
    Arch Med Res. 2018 Apr 23. pii: S0188-4409(18)30121.
    PubMed     Text format     Abstract available

    Cancer Lett

  2. TAO L, Qiu J, Slavin S, Ou Z, et al
    Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor beta/IL-1/c-MET signals.
    Cancer Lett. 2018 Apr 20. pii: S0304-3835(18)30248.
    PubMed     Text format     Abstract available

    Cancer Treat Rev

  3. KHETRAPAL P, Lee MWL, Tan WS, Dong L, et al
    The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review.
    Cancer Treat Rev. 2018;66:56-63.
    PubMed     Text format     Abstract available

    Cell Physiol Biochem

  4. WU S, Zhao X, Wang Y, Zhong Z, et al
    Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
    Cell Physiol Biochem. 2018;46:1352-1364.
    PubMed     Text format     Abstract available

  5. LI P, Yang X, Yuan W, Yang C, et al
    CircRNA-Cdr1as Exerts Anti-Oncogenic Functions in Bladder Cancer by Sponging MicroRNA-135a.
    Cell Physiol Biochem. 2018;46:1606-1616.
    PubMed     Text format     Abstract available

    Cell Signal

  6. HUI K, Wu S, Yue Y, Gu Y, et al
    RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer.
    Cell Signal. 2018 Apr 24. pii: S0898-6568(18)30092.
    PubMed     Text format     Abstract available

    Contemp Clin Trials Commun

  7. VAN DOEVEREN T, van Leeuwen PJ, Aben KKH, van der Aa M, et al
    Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial.
    Contemp Clin Trials Commun. 2018;9:121-129.
    PubMed     Text format     Abstract available

    Curr Urol

  8. GUO Y, Liu Z, Li K, Cao G, et al
    Paris Polyphylla-Derived Saponins Inhibit Growth of Bladder Cancer Cells by Inducing Mutant P53 Degradation While Up-Regulating CDKN1A Expression.
    Curr Urol. 2018;11:131-138.
    PubMed     Text format     Abstract available


  9. MOSCHINI M, Montorsi F
    Preoperative Prediction of Node Metastases in Bladder Cancer Patients Using Genomic and Clinicopathologic Data.
    EBioMedicine. 2018 Apr 7. pii: S2352-3964(18)30134.
    PubMed     Text format    


  10. BOSSCHIETER J, Lutz C, Segerink LI, Vis AN, et al
    The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review.
    Epigenomics. 2018 Apr 25. doi: 10.2217/epi-2017-0156.
    PubMed     Text format     Abstract available

    Eur J Surg Oncol

  11. MISCHINGER J, Abdelhafez MF, Rausch S, Todenhofer T, et al
    Perioperative morbidity, bowel function and oncologic outcome after radical cystectomy and ileal orthotopic neobladder reconstruction: Studer-pouch versus I-pouch.
    Eur J Surg Oncol. 2018;44:178-184.
    PubMed     Text format     Abstract available

    Int J Oncol

  12. YANG X, Yin H, Zhang Y, Li X, et al
    Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1alpha activation.
    Int J Oncol. 2018 Apr 24. doi: 10.3892/ijo.2018.4376.
    PubMed     Text format     Abstract available

    J Cell Biochem

  13. HASHEMI M, Bahari G, Bizhani F, Danesh H, et al
    Evaluation of 4-bp insertion/deletion polymorphism within the 3'UTR of SGSM3 in bladder cancer using mismatch PCR-RFLP method: A preliminary report.
    J Cell Biochem. 2018 Apr 25. doi: 10.1002/jcb.26764.
    PubMed     Text format     Abstract available

    Medicine (Baltimore)

  14. BALAN D, Martha O, Chibelean CB, Tataru S, et al
    Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors.
    Medicine (Baltimore). 2018;97:e0522.
    PubMed     Text format     Abstract available

    Mol Med Rep

  15. ZHANG XF, Zhang XQ, Chang ZX, Wu CC, et al
    microRNA145 modulates migration and invasion of bladder cancer cells by targeting Ncadherin.
    Mol Med Rep. 2018 Apr 20. doi: 10.3892/mmr.2018.8910.
    PubMed     Text format     Abstract available

    Nanomaterials (Basel)

  16. LEE YH, Lin YC
    Anti-EGFR Indocyanine Green-Mitomycin C-Loaded Perfluorocarbon Double Nanoemulsion: A Novel Nanostructure for Targeted Photochemotherapy of Bladder Cancer Cells.
    Nanomaterials (Basel). 2018;8.
    PubMed     Text format     Abstract available

    Onco Targets Ther

  17. HUANG C, Huang Z, Bai P, Luo G, et al
    Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis.
    Onco Targets Ther. 2018;11:2075-2082.
    PubMed     Text format     Abstract available

    Transl Res

  18. ALVAREZ-ARGUEDAS S, Uranga S, Martin M, Elizalde J, et al
    Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancer.
    Transl Res. 2018 Apr 6. pii: S1931-5244(18)30051.
    PubMed     Text format     Abstract available

    Urol Oncol

  19. MARI A, Kimura S, Foerster B, Abufaraj M, et al
    A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
    Urol Oncol. 2018 Apr 20. pii: S1078-1439(18)30114.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.